Journal of Addiction Medicine

Article	Citations
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study	96
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	64
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	58
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	55
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	54
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	47
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	46
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	41
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	38
Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases	37
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	33
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	33
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	32
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation	30
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails	30
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	30
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	30
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	26
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	26
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	26
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	23
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	22
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	22
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	22
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	21

Use of Cannabinoids by People Who Consume Kratom in the United States	21
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	20
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	20
Identifying Areas to Improve Care and Support Parent-Child Relationships From the Perspective of Pregnant and Parenting People in Recovery	19
Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds	18
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	17
Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review	17
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	17
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique	17
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	16
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	16
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	15
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	15
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	15
Fentanyl Test Strips for Harm Reduction: A Scoping Review	14
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	14
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	14
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	13
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	13
Climate Change and the Opioid Epidemic	13
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	13
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat Among US Adults	13
The Association Between Perceived Injustice and Opioid Craving in Patients With Chronic Pain: The Mediating Role of Daily Pain Intensity, Negative Affect, and Catastrophizing	12
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	12
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	12
Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development	12
A Hospital-based Managed Alcohol Program in a Canadian Setting	12
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	12
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	12
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	11
Online Narcotics Anonymous: An Option for Addressing Methamphetamine Use Disorder	11
Insurance-related Risk Factors for Leaving Against Medical Advice after Opioid Overdose: A Cross-sectional Study Using Electronic Health Records	11
Current State of Perioperative Buprenorphine Management—A National Provider Survey	11
Response to: “Prevalence of Kratom Use Disorder among Kratom Consumers”	11
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	10
Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	10
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	10
Letter in Reply	10
The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	9
Aripiprazole Is Not Effective for Abstinence or Decreased Use in Alcohol and Stimulant Use Disorders in Patients Without Psychiatric Comorbidities: A Systematic Review	9
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine	9
ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities	9
Xylazine Test Strip Use Among People Who Use Drugs in New York State	9
The Difficulties in Finding the Relevant Associations Between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	9
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	9
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	9
Retention With Medication for Opioid Use Disorder: The Role of the Primary Care Relationship	9
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	9
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	9
Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	9

Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	9
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	9
Integration of Substance Use Disorder Services in Veterans Affairs Primary Care Clinics Serving Homeless Women	9
Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	9
Addiction Services for Veterans: Opportunities in Acute Care	8
Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	8
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	8
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	8
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	8
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	8
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	8
A Scoping Review of Youth Overdose Prevention Interventions	8
Complexities in Assessing Pregnancy-related Outcomes Among Patients Receiving Interdisciplinary Treatment for an Opioid Use Disorder	8
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	8
N-acetylcysteine Efficacy on Cocaine Base Paste Use Disorder: A Randomized Double-blind Placebo-controlled Clinical Trial	8
Prevalence of Kratom Use Disorder Among Kratom Consumers	7
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	7
Cannabis and Cannabinoids for Treating Pain: What Are the Data?	7
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	7
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	7
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	7
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	7
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	7
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	7
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications	7
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	7
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	7
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	7
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	7
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	7
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	7
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	7
Direct Induction of Buprenorphine Extended-Release: A Case Report	7
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	7
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl	7
Validating the Waterpipe Addiction, Craving, and Anticipation Scale: An Exploratory Factor Analysis	7
Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders	7
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings	7
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	7
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	7
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	6
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	6
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	6
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	6
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	6
Health Care Service Presence, Social Vulnerability, and Opioid Overdose Rate Acceleration: A United States, County-level Analysis, 2020–2022	6
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	6
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	6
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	6
Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals	6
Response to Martins et al.	6
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	6
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	6
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	6
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	6
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	6
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	6
Challenges of Drug Testing in Addiction Treatment	6
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	6
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	6
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing	6
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	6
Response to the Federation of State Physician Health Program's Commentary	6
Exploring Preferences for Communication and Care Among Hospitalized Patients With Opioid Use Disorder: A Qualitative Descriptive Study	5
The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup	5
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	5
The First 100 Days: The Trump Administration and Changes to Addiction Policy	5
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	5
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	5
Participant Experiences of a Quit Smoking Attempt Through Either Nicotine Replacement Therapy (NRT) Methods or the Use of an E-cigarette	5
Circumstances Around Cigarette Use after Enforced Abstinence From Smoking in an American Prison	5
Does Labetalol Trigger False Positive Drug Testing Results?	5
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns	5
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	5
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	5
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	5
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	5
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	5

Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	5
Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	5
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	5
Quetiapine: A Novel Additive to the Illicit Heroin Supply in Los Angeles	5
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	5
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	5
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	5
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	5
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	5
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	5
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	5
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	5
2024 ASAM Annual Conference Poster Abstracts	5
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	5
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	5
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	5
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	5
The Prognostic Role of DSM-5 Alcohol Use Disorder Severity and Age of Onset in Treatment Outcome Among Adults Aged 60+	4
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	4
Privacy and Digital Health: Causes for Concern and a Way Forward	4
Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review	4
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes	4
Evaluation and Management of Buprenorphine Extended-Release Injection Thrombophlebitis: A Case Report	4
Expanding Medical Education to Include Substance Use Disorders During Pregnancy and Postpartum: Preliminary Effectiveness of a Pilot Curriculum for Medical Students	4
Xylazine Positivity in Opioid-positive Drug Screens on an Inpatient Labor Unit	4
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	4
Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques	4
A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment	4
Factors Associated With the Presence of Co-occurring Pain and Substance Use Disorder Programs in Substance Use Treatment Facilities	4
Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents	4
Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients	4
Impact of X-Waiver Elimination on Post–Hospital Discharge Buprenorphine Prescribing: An Interrupted Time Series Analysis	4
Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper	4
Standard Versus Rapid Inpatient Methadone Titration for Pregnant Patients With Opioid Use Disorder: A Retrospective Cohort Study	4
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia	4
A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic	4
Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review	4
Facilitating Integrated Perinatal Care for Families Affected by Substance Use	4
Secondary Analysis to Advance Characterization of On-body Electrocardiographic Sensors in a Clinical Cocaine Self-administration Paradigm	4
Implementation of a Naloxone Best Practice Advisory Into an Electronic Health Record	4
Low-dose Initiation of Buprenorphine in Hospitalized Patients Using Buccal Buprenorphine: A Case Series	4
The Use of Extended-Release Buprenorphine in the Treatment of Adolescent Opioid Use Disorder: A Case Series	4
Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences	4
An Attendance-based Contingency Management Pilot Program for Veterans Experiencing Homelessness With Stimulant-associated Cardiomyopathy in Primary Care	4
Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health Center	4
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOT	4
Response to Avoiding NICU Transfer for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit	4
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial	4
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone	4
Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes	4
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	4
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative	4
Description of Physician Champion Efforts to Expand Buprenorphine Treatment in Primary Care and Explore a Quality Implementation Measure of Success: Buprenorphine as a Percentage of All Opioids Prescr	4
Financial Well-being and Impact on Alcohol and Mental Health Outcomes During the COVID-19 Pandemic	4
Off-label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report	4
Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis	4
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals With an Addiction Consult Service	4
Global, Regional, and National Burdens Attributable to Drug Use Across 204 Countries and Territories Between 1990 and 2021: The Global Burden of Disease Study 2021	4
Early Long-Acting Buprenorphine for Opioid Use Disorder in the Setting of Acute Pain	4
Age-related Psychometric Dimensionality Using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Opioid Use Disorder Diagnostic Criteria	4
The Social Context of Unhealthy Alcohol Use Among Emergency Department Patients: A Cross Sectional Study	4
An Open-label Pilot Study of NicoBloc as a Novel Smoking Cessation Intervention	4
The Associations of Kratom (Mitragynine), Opioids, Other Substances, and Sociodemographic Variables to Drug Intoxication–related Mortality	4
National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders	4
Predictors of Risky Sexual Behaviors Among Female Adolescents and Young Adults Seeking Withdrawal Management Treatment: A Lifestyle-routine Activities Theory Approach	4
Association Between Smoking Abstinence and Depression and Anxiety Symptoms After Hospital Discharge: The Helping HAND 4 Trial	4